Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliana Smith

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
BMC Nephrology|May 1, 2023
Barriers and facilitators to the transplant process among patients living with polycystic kidney disease: a qualitative ApproachJuliana Smith, Orlando O Harris, Deborah Adey, et al.
The Journal of Clinical Psychiatry|June 27, 2007
Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysisGeorge I Papakostas, Richard C Shelton, Juliana Smith, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|April 25, 2007
Hopelessness as a predictor of non-response to fluoxetine in major depressive disorderGeorge I Papakostas, Timothy Petersen, Caitlin H Homberger, et al.
Neuropsychiatric Disease and Treatment|March 21, 2009
A survey of five antidepressant properties influencing clinician's treatment choices in MDDGeorge I Papakostas, Lindsay A Hallett, Juliana Smith, et al.
The Journal of Clinical Psychiatry|August 28, 2009
A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorderDavid Mischoulon, George I Papakostas, Christina M Dording, et al.
Surgery|May 18, 2026
Postoperative outcomes of Morel-Lavallee injuries and predictive factors for wound complications: A Pacific Coast Surgical Association multicenter studyPeter D Nguyen, Areg Grigorian, Todd Costantini, et al.
The American Surgeon|April 16, 2026
Operative Strategies and Wound Complications for Morel-Lavallee Injuries Undergoing Excisional Debridement: A Pacific Coast Surgical Association Multicenter StudyPeter D Nguyen, Areg Grigorian, Todd Costantini, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMC Nephrology|May 1, 2023
Barriers and facilitators to the transplant process among patients living with polycystic kidney disease: a qualitative ApproachJuliana Smith, Orlando O Harris, Deborah Adey, et al.
The Journal of Clinical Psychiatry|June 27, 2007
Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysisGeorge I Papakostas, Richard C Shelton, Juliana Smith, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|April 25, 2007
Hopelessness as a predictor of non-response to fluoxetine in major depressive disorderGeorge I Papakostas, Timothy Petersen, Caitlin H Homberger, et al.
Neuropsychiatric Disease and Treatment|March 21, 2009
A survey of five antidepressant properties influencing clinician's treatment choices in MDDGeorge I Papakostas, Lindsay A Hallett, Juliana Smith, et al.
The Journal of Clinical Psychiatry|August 28, 2009
A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorderDavid Mischoulon, George I Papakostas, Christina M Dording, et al.
Surgery|May 18, 2026
Postoperative outcomes of Morel-Lavallee injuries and predictive factors for wound complications: A Pacific Coast Surgical Association multicenter studyPeter D Nguyen, Areg Grigorian, Todd Costantini, et al.
The American Surgeon|April 16, 2026
Operative Strategies and Wound Complications for Morel-Lavallee Injuries Undergoing Excisional Debridement: A Pacific Coast Surgical Association Multicenter StudyPeter D Nguyen, Areg Grigorian, Todd Costantini, et al.
Pageof 1